Floatz logo

AE-BROCCOLI

Lobular Breast Carcinoma

Roswell Park Cancer InstitutemixtureEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

1 Active assets in the Lobular Breast Carcinoma cohort.

Asset / SponsorPhaseRating
FULVESTRANT
Royal Marsden NHS Foundation Trust
Phase 2B
Crizotinib
Royal Marsden NHS Foundation Trust
Phase 2B
FFNP
University of Wisconsin, Madison
Phase 2CCC
Naltrexone
Dana-Farber Cancer Institute
Phase 2CCC

Same molecule, other indications

AE-BROCCOLI is also rated in:

breast cancerDormant
CCC
Indicative ·
53 / 100
View asset →
breast ductal adenocarcinomaDormant
CC
Indicative ·
43 / 100
View asset →
ductal breast carcinoma in situDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →